This report is the result of a consultative and deliberative process — initiated by the Belgian Healthcare Knowledge Centre (KCE) and Zorginstituut Nederland (Dutch Health Care Institute, ZIN) — to explore
in an unfettered way potential solutions to the complex societal challenge of high drug prices. The aim of the project was to elaborate creative scenarios and to explore novel, more sustainable ways to ensure patient access to safe and effective drugs, while providing strong incentives for innovation and focussing on real health needs.

The scenario project benefited from the active contribution of a carefully selected group of experts and stakeholders from Europe and North America, including patient representatives, industry leaders, academics, regulators, payers, and government representatives. This report presents four coherent scenarios, developed on the basis of in-depth interviews of the experts, followed by two 2-day deliberative workshops in Amsterdam, in March and April 2016.

One of the authors of the summary document is Philippe Vandenbroeck (shiftN). ShiftN is one of the partners in the International Certified Future Strategist programme.

This summary document reports the key findings resulting from this work.